Hippocratic AI, announced the launch of its Early Access Partnership Program, bringing together leaders in the healthcare industry to support the development of Hippocratic AI’s technology and validate priority use cases. The program will include leading health systems and digital health companies, including OhioHealth, Roper St. Francis Healthcare, Evernow, HarmonyCares, and Guidehealth, among many others.
“We believe generative AI holds incredible potential to advance on the promise of technology to deliver meaningful transformation and efficiency for our caregivers and our patients. Its continued evolution requires input from industry professionals who can ensure safety and identify priority applications,” said Michael Krouse, Chief Strategy and Transformation Officer, OhioHealth. “Our system spans 15 hospitals, 50 counties and includes more than 5000 physicians devoted to providing exceptional care for all. Combining our scope in terms of patients and workforce with Hippocratic AI’s focus on non-diagnostic solutions is the right formula for ensuring the technology is developed and deployed safely and with integrity. Our team is excited to play a hands-on role in guiding Hippocratic AI’s technology from its early stages, and we look forward to collaborating in pursuit of better and more equitable healthcare outcomes.”
Hippocratic AI is building the industry’s first safety-focused Large Language Model (LLM) designed specifically for healthcare, with an initial emphasis on patient-facing, non-diagnostic applications. To build a safer LLM, Hippocratic AI has implemented a multi-faceted approach in creating its product, including: outperforming GPT-4 on over 100 healthcare certifications, training on healthcare specific vocabulary, reinforcement learning with human feedback (RLHF) via healthcare professionals, and working closely with industry experts to verify the model is truly safe.
Also Read : Jorie AI’s Vibrant Debut at HLTH 2023: The Future of Healthcare Revenue Cycle Management
“I’m excited about exploring our options for patient care with Hippocratic AI,” said Michael Millie, MD, CMO at HarmonyCares. “Advancing technology in healthcare is key to improving our performance and delivering expert care to the patients we serve. It’s our collective future. As we develop more pathways for our patients to experience more immediate and effective care engagement, making the most of what medical technology has to offer will continue to drive us forward in delivering high-quality care and personalized options.”
“We see tremendous opportunity to support the needs of patients in value-based care contracts,” said Michael Gleeson, Co-founder and CTO at Guidehealth. “Hippocratic AI allows us to keep track of what is happening to patients outside the exam room, by getting frequent wellness and clinical updates directly from the patient. This allows us to expand our reach to patients with rising risk, while focusing our team on more complex patients, helping us improve patient health outcomes and value-based contract performance.”
“In the U.S. where there is only one licensed menopause practitioner per 33,000 women we believe technologies like Hippocratic AI have the potential to help every woman access world class care,” said Alicia Jackson, CEO and Founder of Evernow. “We’re proud to be the only Early Access Partner in women’s health and look forward to leveraging Hippocratic AI to improve the depth and quality of care our members receive at Evernow.”
Early Access Partners will play an integral role in shaping Hippocratic AI’s product-market fit and design priorities, and provide clinical insight into the final commercial product suite. Given early access to Hippocratic AI’s products, the partners will:
- Collaborate on designing ideal workflows to address key health system problems, staffing gaps, and care improvement opportunities
- Contribute both clinical and non-clinical resources to support the development of initial use cases
- Aid in education and advocacy of safe development, implementation and governance of AI in healthcare
- Pilot early use cases in sandbox environments and determine readiness for deployment
“Hippocratic AI is on a mission to increase access and equity, and provide an unprecedented level of care, but we can’t do it alone. That’s why collaboration is so fundamental to everything we do,” said Meenesh Bhimani MD, Co-Founder & Chief Medical Officer of Hippocratic AI. “It is humbling to be working alongside industry leaders to help develop the safest and most effective LLM for healthcare. We are fully committed to collaborating with industry partners to guide the development of a technology with the potential to address critical staffing shortages and revolutionize healthcare delivery.”
SOURCE : GlobeNewswire
